Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quanterix Corporation - Common Stock (NQ: QTRX )

5.420 +0.080 (+1.50%)
Streaming Delayed Price Updated: 11:48 AM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Quanterix Announces Appointment of Karen A. Flynn to Board of Directors
From Quanterix Corporation
Via Business Wire
Quanterix Corporation Releases Operating Results for First Quarter 2022
From Quanterix Corporation
Via Business Wire
Earnings Preview For Quanterix
Quanterix (NASDAQ:QTRX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Quanterix will... 
Via Benzinga
Quanterix Corporation to Release First Quarter 2022 Financial Results on May 10, 2022
From Quanterix Corporation
Via Business Wire
Recap: Quanterix Q4 Earnings
Quanterix (NASDAQ:QTRX) reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million. 
Via Benzinga
Quanterix Receives FDA Breakthrough Device Tag For NfL Test For Multiple Sclerosis
Quanterix Corp (NASDAQ: QTRX) received FDA breakthrough device designation for multiple sclerosis (MS) diagnostic. Quanterix designed its Simoa neurofilament light... 
Via Benzinga
Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis
From Quanterix Corporation
Via Business Wire
What 4 Analyst Ratings Have To Say About Quanterix
Over the past 3 months, 4 analysts have published their opinion on Quanterix (NASDAQ:QTRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Quanterix’ Simoa® Technology Powers Large, International Comprehensive Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Disease Activity in Multiple Sclerosis (MS) Patients
From Quanterix Corporation
Via Business Wire
Quanterix Receives Funding from the Alzheimer’s Drug Discovery Foundation to Accelerate Alzheimer’s Disease Diagnostic Plasma Test Development
From Quanterix Corporation
Via Business Wire
Quanterix's Return On Capital Employed Insights
Quanterix (NASDAQ:QTRX) brought in sales totaling $30.29 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 27.87%, resulting in a loss of $... 
Via Benzinga
Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
From Quanterix Corporation
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2022
Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth... 
Via Benzinga
Quanterix to Participate in the SVB Leerink Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
UK Dementia Research Institute Biomarker Factory Powers Alzheimer’s Disease Breakthroughs with Quanterix Simoa® Technology
From Quanterix Corporation
Via Business Wire
Quanterix’ Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multiple Sclerosis
From Quanterix
Via Business Wire
Quanterix Provides Operational and Preliminary Financial Highlights
From Quanterix Corporation
Via Business Wire
Quanterix to Present at 40th Annual J.P. Morgan Healthcare Conference
From Quanterix Corporation
Via Business Wire
Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™
From Quanterix Corporation
Via Business Wire
Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
From Quanterix Corporation
Via Business Wire
Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
From Quanterix Corporation
Via Business Wire
Quanterix Co-Inventor of Simoa® David Walt Receives Kabiller Prize in Nanoscience and Nanomedicine
From Quanterix Corporation
Via Business Wire
Quanterix Corporation (QTRX) Q3 2021 Earnings Call Transcript
QTRX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Quanterix Corporation Releases Operating Results for Third Quarter of 2021
From Quanterix
Via Business Wire
Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021
From Quanterix
Via Business Wire
45 Biggest Movers From Yesterday
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.